Recombia was founded in 2019 as a spinout of the Stanford Genome Technology Center. The company is based on technologies for enhanced high throughput genome editing and synthetic biology and will use these technologies to discover ways in which industrial strains of yeast can be improved for manufacturing different products. Our focus is on metabolic engineering and strain engineering to produce high value compounds and strains of microorganisms.
In September 2022, we were acquired by Lesaffre, a global player in the fermentation of microorganisms (yeasts, bacterias) for baking, taste, healthcare & biotechnology. We are now a fully owned subsidiary of Lesaffre.
Are headquarters are located on the western shore of San Francisco Bay, a few miles south of the city of San Francisco and in the heart of the area’s biotechnology hub. In 2023 we expanded to a second location near Boston with a focus on metabolic engineering in a diversity of microorganisms.